全文获取类型
收费全文 | 445391篇 |
免费 | 41467篇 |
国内免费 | 13947篇 |
专业分类
耳鼻咽喉 | 4722篇 |
儿科学 | 10476篇 |
妇产科学 | 8167篇 |
基础医学 | 32691篇 |
口腔科学 | 6558篇 |
临床医学 | 44852篇 |
内科学 | 61659篇 |
皮肤病学 | 4455篇 |
神经病学 | 15522篇 |
特种医学 | 18503篇 |
外国民族医学 | 271篇 |
外科学 | 64678篇 |
综合类 | 48914篇 |
现状与发展 | 61篇 |
一般理论 | 3篇 |
预防医学 | 25396篇 |
眼科学 | 5486篇 |
药学 | 40813篇 |
222篇 | |
中国医学 | 13264篇 |
肿瘤学 | 94092篇 |
出版年
2024年 | 811篇 |
2023年 | 6566篇 |
2022年 | 10953篇 |
2021年 | 22058篇 |
2020年 | 16627篇 |
2019年 | 20866篇 |
2018年 | 15509篇 |
2017年 | 15236篇 |
2016年 | 17799篇 |
2015年 | 21890篇 |
2014年 | 36069篇 |
2013年 | 33741篇 |
2012年 | 33615篇 |
2011年 | 30839篇 |
2010年 | 25393篇 |
2009年 | 25151篇 |
2008年 | 24008篇 |
2007年 | 23422篇 |
2006年 | 20110篇 |
2005年 | 14704篇 |
2004年 | 9860篇 |
2003年 | 8345篇 |
2002年 | 6933篇 |
2001年 | 6068篇 |
2000年 | 5164篇 |
1999年 | 3995篇 |
1998年 | 4019篇 |
1997年 | 3657篇 |
1996年 | 3002篇 |
1995年 | 2871篇 |
1994年 | 2588篇 |
1993年 | 2028篇 |
1992年 | 2129篇 |
1991年 | 1850篇 |
1990年 | 1727篇 |
1989年 | 1632篇 |
1988年 | 1444篇 |
1987年 | 1296篇 |
1986年 | 1077篇 |
1985年 | 2061篇 |
1984年 | 2147篇 |
1983年 | 1485篇 |
1982年 | 1623篇 |
1981年 | 1590篇 |
1980年 | 1364篇 |
1979年 | 1149篇 |
1978年 | 875篇 |
1977年 | 859篇 |
1976年 | 748篇 |
1975年 | 488篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
991.
鼻咽癌常规放疗靶体积合理性的初步探讨 总被引:2,自引:0,他引:2
目的分析鼻咽癌常规放疗的局部控制情况和局部复发的剂量学模式,初步探讨照射靶体积确定的合理性.方法共476例初治鼻咽癌患者接受规范化单纯常规根治性放疗.全部病例均采用常规模拟定位,鼻咽靶体积为CT检查所见的原发病灶范围以及可能侵犯的亚临床病灶区域.利用Kaplan-Meier方法计算局部累积复发率;将鼻咽局部复发患者疗前和复发时局部病灶范围(Vnx和Vrecur)勾画于三维治疗计划系统,复制首程放疗的射野并按原处方剂量进行计算,根据剂量体积直方图进行剂量学评价:recurV95(95%处方剂量曲线包括的Vrecur)≥95%定义为野内复发,95%>recurV95≥20%定义为野边缘复发,20%>recurV95定义为野外复发.结果局部复发共52例,全组1、2、3、4年局部累积复发率分别为0.6%、3.9%、8.7%、11.5%.对42例局部复发的剂量学分析显示野内复发占多数(52%),而大部分野边缘复发和全部野外复发均与射野设置不当、影像学阅片能力欠缺使首程放疗剂量不足有关.结论较好的局部控制率、复发的剂量学模式的分析结果提示该靶体积的设置比较合理.提高影像阅片能力,准确的射野设计,充分利用生物影像学工具,有针对性地提高照射剂量,有望进一步提高局部控制率. 相似文献
992.
老年腹主动脉瘤非手术治疗的长期超声随访研究 总被引:5,自引:0,他引:5
目的超声随访观察经非手术治疗的老年腹主动脉瘤的发展变化规律。方法超声随访诊断明确、病历及影像学资料完整的老年腹主动脉瘤非手术治疗患者37例,按首次发现时瘤体大小分3组,定期测量并记录各组腹主动脉扩张最明显处横切面直径,计算年增长量。结果37例腹主动脉瘤首次发现时瘤径大小平均为4.68cm,随访年限0.5~11年,平均6.1年,瘤径平均每年增长0.47cm。14例瘤径小于4.0cm,平均年增长0.23cm,15例瘤径小于6.0cm,平均年增长0.37cm,8例瘤径大于6.0cm,平均年增长0.67cm。随访期间死亡5例,其中因动脉瘤破裂死亡2例,破裂前瘤径大小分别为8.35cm、8.91cm。7例随访期间因瘤径短期内明显增大而行腹主动脉瘤腔内支架隔绝术。结论老年腹主动脉瘤瘤径小于6.0cm者随增龄增长缓慢,大于6.0cm者随增龄增长快,应进行积极的外科干预。 相似文献
993.
Crohn病的CT表现 总被引:7,自引:1,他引:6
目的探讨Crohn病的CT表现特点。方法回顾性分析经病理证实的18例Crohn病的CT征象,大多数病例采用螺旋CT或多层螺旋CT扫描。结果所有病例均有节段性肠壁增厚,CT增强有7例表现为肠壁均匀增厚,缺乏层次,同时肠壁强化不明显;有11例表现为黏膜增厚和分层形成“靶征”和“双环征”,肠壁厚度多在5~10mm;有9例表现为病变段肠管周围纤维脂肪成分增多,蜂窝织炎及肠周或肠系膜血管增多增粗。有5例CT首先考虑为其他疾病,1例考虑为闭攀性肠梗阻,1例首先考虑为肠结核,2例回盲部病变怀疑为癌,1例肠穿孔形成脓肿仅诊为化脓性感染。结论cT不但能准确显示Crohn病肠壁、肠系膜及周围结构的异常,增强CT还能区分活动性与非活动性病变,有助于临床采取合理而积极的治疗方案。 相似文献
994.
Andreas Blana Stefan Denzinger Markus Lenhart Wolf F Wieland Roman Ganzer 《International journal of urology》2007,14(5):450-451
We report a case of recurrent inguinal lymphocele formation after inguinal lymphadenectomy treated by lymphographic mapping and selective ligation of the lymphatic vessels. Lymphographic mapping was performed by puncturing a lymphatic vessel at the dorsum of the foot. After isolating the vessels that drained into the lymphocele, they were clipped and divided through a small skin incision. The described technique showed an instant and complete suspension of the lymph secretion with subsequent complete healing. Lymphatic mapping and selective ligation of afferent lymphatic vessels proved to be an effective treatment of a recurrent inguinal lymphocele. 相似文献
995.
996.
Keishi Kashibuchi Kyoichi Tomita Jack A Schalken Haruki Kume Takumi Takeuchi Tadaichi Kitamura 《International journal of urology》2007,14(9):789-794
OBJECTIVES: To determine the value of the loss of expression of E-cadherin and cadherin associated molecules as useful markers for both prognosis and chemosensitivity in bladder cancer patients who have undergone radical cystectomy. PATIENTS AND METHODS: In 55 paraffin embedded specimens of radical cystectomy at our hospital from 1982 to 2000, the expression of E-cadherin, alpha-, beta- and gamma-catenin was examined by immunohistochemical staining. To evaluate the prognostic significance of these molecules, Kaplan-Meier survival curves were constructed and a statistical analysis was calculated by a log-rank test. A multivariate test (tumor stage, tumor grade, lymph node metastasis, configuration, the expression of E-cadherin, alpha-, beta- and gamma-catenin) was performed to detect prognostic markers. RESULTS: Normal expression was found in 33 cases (60.0%) for E-cadherin, 29 (52.7%) for alpha-catenin, 31 cases (56.4%) for beta-catenin, and 31 cases (56.4%) for gamma-catenin. The expression patterns for E-cadherin, alpha-, beta- and gamma-catenin were significantly correlated with each other (P < 0.01). Survival analysis showed a significant difference between normal and aberrant expression in each staining. A multivariate analysis revealed that the expression of alpha- catenin was an independent prognostic factor (P = 0.0191). In 23 patients that received adjuvant chemotherapy, there was a significant difference in survival between the normal and aberrant expression of alpha-catenin, but not other molecules. CONCLUSION: Alpha-catenin may not only be a good prognostic marker, but also one of key molecules that determine the chemosensitivities in patients with invasive bladder cancer. 相似文献
997.
Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer 总被引:1,自引:1,他引:0
Toshikazu Okaneya Shuji Nishizawa Tsuyoshi Nakayama Takayuki Kamigaito Iwao Hashida Noriko Hosaka 《International journal of urology》2007,14(7):602-606
OBJECTIVE: To evaluate the initial results of brachytherapy for prostate cancer with permanent iodine-125 implant in Japan. METHODS: The results obtained with brachytherapy in the initial 100 Japanese patients treated at Nagano Municipal Hospital were reviewed. Patients with a prostate-specific antigen (PSA) level of less than 10 ng/mL and a Gleason's scores of 5, 6, 3 + 4 were classified as having a low risk of recurrence. Patients with a PSA level of 10-20 ng/mL and/or a Gleason's score of 4 + 3 were classified as having an intermediate risk for recurrence. Seventy-eight of the low-risk patients and 19 of the intermediate-risk patients were treated by seed implants alone, or seed implants combined with preceding external radiation, respectively. A total of 53 patients received neoadjuvant hormone therapy. The efficacy and morbidity of brachytherapy were investigated using the serum PSA, International Prostate Symptom Score, quality of life score and uroflowmetry data. RESULTS: The average V100 and D90 obtained by post-implant dosimetry was 94.3 and 113.7%, respectively. Serum PSA decreased gradually after treatment, although it had still not reached a nadir after 1 year. There was little difference of the PSA level between the patients with and without neoadjuvant hormone therapy even at 1 year after seed implantation. There were no PSA biochemical failure or clinical recurrence during the follow-up period. Voiding symptoms worsened until 3 months after treatment, and then gradually improved. Acute urinary retention occurred transiently in one patient (1%). Rectal bleeding and severe diarrhea did not occur. CONCLUSION: Brachytherapy is a feasible and effective option for the treatment of prostate cancer in Japanese men. Brachytherapy may have a different effect in Japanese patients with respect to voiding symptoms. Urinary retention was rare, but voiding symptoms were persistent in Japanese patients. Neoadjuvant hormone therapy deserves investigation to determine whether it can achieve better results, especially in patients with an intermediate risk. 相似文献
998.
Testicular cancer with tumor thrombus extending to the inferior vena cava successfully removed using veno-venous bypass: A case report 总被引:1,自引:0,他引:1
Yoshiaki Kinebuchi Teruyuki Ogawa Haruaki Kato Yasuhiko Igawa Osamu Nishizawa Shin-Ichi Miyagawa 《International journal of urology》2007,14(5):458-460
A 33-year-old man with a left testicular tumor was referred to Shinshu University Hospital for advanced therapy. Radiographic imaging revealed multiple metastases in the retroperitoneal lymph nodes (RPLN) and bilateral lungs, as well as tumor thrombus that extended from the left renal vein to the inferior vena cava (IVC) adjacent to the right atrium. After orchidectomy, a diagnosis of embryonal carcinoma was made with a clinical stage of T1N2M1bS3, which has a poor prognosis, based on the International Germ Cell Cancer Collaborative Group consensus. After eight courses of chemotherapy, the patient's tumor markers normalized and the lung metastases disappeared, but the RPLN and tumor thrombus remained. Retroperitoneal lymph node dissection and thrombectomy were performed using a veno-venous bypass (VVB). The pathological examination of the thrombus revealed a mature teratoma. The patient has been disease-free since surgery. 相似文献
999.
1000.